<DOC>
	<DOCNO>NCT01572948</DOCNO>
	<brief_summary>The purpose study propose roflumilast associate meaningful reduction biomarkers pulmonary inflammation sputum neutrophilia , include confirmation previously describe result , correlate finding improvement pulmonary function , sputum score , quality life stable moderate severe COPD . The investigator aim demonstrate regardless concomitant medication use , include inhaled corticosteroid . Additionally , investigator hope provide mechanistic pathway effect occur .</brief_summary>
	<brief_title>A Placebo-controlled Trial Daliresp Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>1 . Male female subject , &gt; 40 year age 2 . Clinical diagnosis moderate severe COPD define GOLD criterion : Postbronchodilator FEV1/FVC &lt; 70 % Postbronchodilator FEV1 &lt; 70 % predict 3 . Cigarette consumption 10 packyears . Patients may active smoker . 4 . The presence chronic cough sputum production 5 . Willingness make return visit telephone availability study duration 1 . A diagnosis asthma establish study investigator basis recent American Thoracic Society/European Respiratory Society guideline 2 . Clinically significant bronchiectasis 3 . Oxygen use &gt; 12 hours/day 4 . Known sensitivity roflumilast 5 . Use methylxanthines within 1 month ( theophylline ) 6 . Changes current maintenance COPD therapy within one month 7 . Pregnancy 8 . An acute illness require antibiotic and/or corticosteroid within month prior enrolment . 9 . Immunosuppression 1 . HIV 2 . Solid organ transplant 3 . Active malignancy 4 . Systemic corticosteroid use â‰¥ prednisone 20mg / day 5 . Other immunosuppressant 10 . Terminal illness define anticipated survival &lt; 12 month 11 . Severe comorbidities include uncontrolled angina , congestive heart failure , endstage renal disease , liver failure , condition would preclude patient safely complete require test study .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>